Introduction
A person's environment, diet and overall health can inß uence how s/he responds to medicines. Genes are another factor which determining a person's response to drugs. Pharmacogenetics aims to understand the role of a person's genetic make-up play in the good effects and side-effects of a medicine in a person's body. A thorough knowledge of this will lead to a future where tailor-made drugs, suited for an individual, can be used.
Pharmacogenetics is the study of genetic basis in the individual response to drugs. A thorough knowledge of this will lead to a future where tailor-made drugs, suiting an individual, can be used. Scandinavian countries have been known for wide usage of pharmacogenetics and the most widely used application is for genotyping CYP2D6 in treating psychiatric illness. The CYP-450 enzyme, a super family of microsomal drug-metabolizing enzymes, is the most important of enzymes that catalyzes phase-I drug metabolism reaction. CYP2D6 is a member of this family and it has been most intensively studied and the best example of pharmacogenetics variation in drug metabolism. Neuro-transmitter and drug acting CNS viz. codeine, dextromethorphan, metoprolol and tryptyline etc. are well metabolized by this enzyme. Thus, CYP2D6 is one of the most important and responsible enzymes which regulates bioavailability and metabolism of drug. Presently 75 alleles of CYP2D6 have been described which are responsible for variance of metabolism and toxicity of drugs. Thus, by determining variance of CYP2D6 using molecular approaches viz., PCR, real-time PCR, DNA micro-array and molecular docking can determine the adverse effects, drug toxicity, bioavailability and therapeutic potential of new drug.
proÞ le were unable to taste PTU, while others could. Pharmacogentics played a major role in understanding the cause and led to an entirely new approach to treatment. Till date, it is widely known that reaction to cancer treatment can very widely from patient from patient to patient. [1] 
Pharmacokinetic Variations

Drug metabolism
Metabolism usually converts drug to metabolites which are more water soluble and thus more easily excreted.
It can also convert products into therapeutically active compounds and may even result in the formation of toxic metabolites.
Pathway of drug metabolism is classiÞ ed as: Table 1 ].
[2] while those with E4 do not.
[4]
Ethical issues
The idea of targeting certain groups within population can be a touching subject, no matter how well intentioned, 
Merits
• Drugs may be developed targeting speciÞ c health problems that will maximize therapeutic effects but not decrease healthy cells.
• The likely hard of adverse effects might be reduced by having an idea of the drug to be used based on genetic proÞ ling.
• Better vaccines made of genetic material having all the beneÞ ts of existing vaccines but with reduced risk of infections.
• The likelihood of over-dosage may be less if dosage were based on a persons genetic makeup rather than a body weight or age • Pharmacogenetics can be used in testing for reaction to is environmental toxins. This finds reference in today's times. Since many areas have high carcinogenic agents individuals susceptible to safe place for them to live a normal, healthy life.
• Revival of older drugs e.g. Clozapine where agranulocytes in 0.5 to 2% of patients limits the use of this agent as Þ rst therapy for Schizophrenia despite its proven efÞ cacy.
Results and Discussion
In some cases, the differences in drug responses can be correlated to ethnic background Noteworthy is the variation in drug metabolism enzyme in various ethnic groups [ Table 2 ]. [5] 
Conclusion
The ramiÞ cation of Pharmacogentics is the ability to screen potential adverse reactions. 
